Diminishing impact of in-lab complications.
Tommaso
C L
CL
Bergelson
B A
BA
D015906:Angioplasty, Balloon, Coronary / Q000009:adverse effects*; D003251:Constriction, Pathologic; D003327:Coronary Disease / Q000209:etiology / Q000517:prevention & control*; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006801:Humans; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use*; D013927:Thrombosis / Q000209:etiology / Q000517:prevention & control
D005343:Fibrinolytic Agents; D010975:Platelet Aggregation Inhibitors